CDT Equity CDT
NASDAQ CDT
$0.34 -0.26 (-42.54%)
As of: Sep 10, 2026 · 3:59 PM EDT

CDT Equity (CDT) Cash from Operations (2022 - 2026)

CDT Equity's (CDT) quarterly Cash from Operations came in at -$4.3 million in Q2 2026, down 68.14% on a YoY basis from -$13.6 million in Q2 2025, and down 328.32% quarter-over-quarter from $1.9 million in Q1 2026.

Analysis

CDT Equity (CDT) Cash from Operations (2022 - 2026) Analysis & Trends

CDT Equity (CDT) has reported Cash from Operations for 5 consecutive years, with -$4.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Operations fell 68.14% year-over-year to -$4.3 million; the trailing twelve-month figure through Jun 2026 stood at -$11.5 million (up 6.34% YoY), and the FY2025 full-year result was -$15.6 million, down 60.82% from the prior year.
  • Cash from Operations slipped to -$4.3 million in Q2 2026 per CDT's latest filing, from $1.9 million in the prior quarter.
  • Across five years, Cash from Operations topped out at $1.9 million in Q1 2026 and bottomed at -$4.8 million in Q4 2023.
  • Historically, Cash from Operations has averaged -$2.1 million across 5 years, with a median of -$2.0 million in 2023.
  • The sharpest annual moves came in 2023 and 2026: Cash from Operations tumbled 433.67% in 2023, then soared 148.36% in 2026.
  • Over 5 years, Cash from Operations stood at -$900000.0 in 2022, then sank by 433.67% to -$4.8 million in 2023, then increased by 20.88% to -$3.8 million in 2024, then slipped by 23.18% to -$4.7 million in 2025, then gained by 7.33% to -$4.3 million in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered -$4.3 million, $1.9 million, and -$4.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 8.62 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 3.44 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 5.88 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 835.00 Mn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 3.44 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - -387.32 Mn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 507.66 Mn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 313.60 Mn
10 CDT Equity 187,135.95 187,135.95 - -4.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.34 Mn
Mar 31, 2026 1.90 Mn
Dec 31, 2025 -4.68 Mn
Sep 30, 2025 -4.41 Mn
Jun 30, 2025 -2.58 Mn
Mar 31, 2025 -3.93 Mn
Dec 31, 2024 -3.80 Mn
Sep 30, 2024 -2.00 Mn
Jun 30, 2024 -1.50 Mn
Mar 31, 2024 -2.40 Mn
Dec 31, 2023 -4.80 Mn
Sep 30, 2023 -522,000.00
Jun 30, 2023 -400,000.00
Mar 31, 2023 -2.00 Mn
Dec 31, 2022 -900,000.00
Sep 30, 2022 -580,600.00
Jun 30, 2022 -126,915.00
Mar 31, 2022 -692,485.00